Dermata Therapeutics Stock Forecast - Daily Balance Of Power

DRMA Stock  USD 1.13  0.03  2.73%   
Dermata Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Dermata Therapeutics stock prices and determine the direction of Dermata Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Dermata Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
The current year's Payables Turnover is expected to grow to 0. As of December 1, 2024, Common Stock Shares Outstanding is expected to decline to about 185.2 K. In addition to that, Net Loss is expected to decline to about (9.1 M).
On September 13, 2024 Dermata Therapeutics had Daily Balance Of Power of 0.32. Balance of Power indicator (or BOP) measures the strength of Dermata Therapeutics market sensitivity to bulls and bears. It estimates the ability of Dermata Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Dermata Therapeutics Balance of Power indicator one can determine a trend of the price direction.
Check Dermata Therapeutics VolatilityBacktest Dermata TherapeuticsTrend Details  

Dermata Therapeutics Trading Date Momentum

On September 16 2024 Dermata Therapeutics was traded for  2.32  at the closing time. The top price for the day was 2.49  and the lowest listed price was  1.86 . The trading volume for the day was 24.2 M. The trading history from September 16, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 46.84% . The overall trading delta against the current closing price is 22.15% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Dermata Therapeutics to competition

Other Forecasting Options for Dermata Therapeutics

For every potential investor in Dermata, whether a beginner or expert, Dermata Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dermata Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dermata. Basic forecasting techniques help filter out the noise by identifying Dermata Therapeutics' price trends.

View Dermata Therapeutics Related Equities

 Risk & Return  Correlation

Dermata Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Dermata Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Dermata Therapeutics' current price.

Dermata Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Dermata Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dermata Therapeutics shares will generate the highest return on investment. By undertsting and applying Dermata Therapeutics stock market strength indicators, traders can identify Dermata Therapeutics entry and exit signals to maximize returns.

Dermata Therapeutics Risk Indicators

The analysis of Dermata Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dermata Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dermata stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Dermata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermata Therapeutics Stock:
Check out Historical Fundamental Analysis of Dermata Therapeutics to cross-verify your projections.
For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(13.36)
Return On Assets
(0.91)
Return On Equity
(1.73)
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.